Insilicos Awarded Grant to Study Heart Disease

Insilicos today announced that the National Heart, Lung, and Blood Institute has awarded Insilicos a two-year, $400,000 grant to develop a blood test for heart disease. A successful test could identify people at risk for heart attacks, when there is still time to prevent a heart attack.
"Heart disease kills more Americans each year than any other disease, claiming almost a million people every year," said Insilicos Chief Scientist Dr. Bryan Prazen, Principal Investigator on the grant. "We're excited to be working with the NIH to address this serious health problem."
To conduct the research, Insilicos will use patent-pending techniques to sensitively analyze blood samples. "Current diagnostic techniques are expensive, unpleasant for the patient, and ultimately not very accurate," said Insilicos President Erik Nilsson. "A better test for heart disease is needed, and we're honored to have the chance to work on it."
Insilicos LLC develops life science software for pharmaceutical development, biological research and clinical diagnostics.
For more information, visit the Insilicos web site www.insilicos.com or contact Insilicos at info@insilicos.com. 'Insilicos' and 'Life Science Software' are trademarks of Insilicos LLC.